EP is a 28-year-old patient who presents to the clinic complaining of “feeling down”. They have gained 15 pounds during the last year, complain of not having any energy and difficulties falling asleep. The attending clinician diagnoses them with depression and wants to prescribe the antidepressant paroxetine (an SSRI (selective serotonin reuptake inhibitor)). They ask you as the pharmacist about pharmacogenomic considerations. You consult the CPIC (Clinical Pharmacogenetics Implementation Consortium) guidelines and find that variations in CYP2D6 can influence the metabolism of paroxetine. Paroxetine is metabolized by CYP2D6 to compounds with little pharmacological activity. You find the following information in the table (through the CPIC guidelines) Q.1 What does the *1 nomenclature signify? A- Only 1% of the population have this genotype B- Normal or reference genotype C- No enzymatic function is associated with this genotype Q.2 What does this designation tell you: *4/*10 A- Haploid, homozygous B- Haploid, heterozygous C- Diploid, homozygous D- Diploid, heterozygous Q.3 CYP2D6*1E correspond to 1870T>C. This is an example of a(n): A- SNP B- Indel C- Copy number variation

Phlebotomy Essentials
6th Edition
ISBN:9781451194524
Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Chapter1: Phlebotomy: Past And Present And The Healthcare Setting
Section: Chapter Questions
Problem 1SRQ
icon
Related questions
Question
100%

EP is a 28-year-old patient who presents to the clinic complaining of “feeling down”. They have gained 15 pounds during the last year, complain of not having any energy and difficulties falling asleep. The attending clinician diagnoses them with depression and wants to prescribe the antidepressant paroxetine (an SSRI (selective serotonin reuptake inhibitor)). They ask you as the pharmacist about pharmacogenomic considerations. You consult the CPIC (Clinical Pharmacogenetics Implementation Consortium) guidelines and find that variations in CYP2D6 can influence the metabolism of paroxetine. Paroxetine is metabolized by CYP2D6 to compounds with little pharmacological activity.

 

You find the following information in the table (through the CPIC guidelines)

Q.1 What does the *1 nomenclature signify?

A- Only 1% of the population have this genotype

B- Normal or reference genotype

C- No enzymatic function is associated with this genotype

 

Q.2 What does this designation tell you: *4/*10

A- Haploid, homozygous

B- Haploid, heterozygous

C- Diploid, homozygous

D- Diploid, heterozygous

 

Q.3 CYP2D6*1E correspond to 1870T>C. This is an example of a(n):

A- SNP

B- Indel

C- Copy number variation

 

Table 1 Assignment of likely phenotypes based on diplotypes
Table 1a Assignment of CYP2D6 predicted phenotypes
Likely phenotype
Activity score
Genotypes
Examples of CYP2D6 diplotypes
Ultrarapid metabolizer
> 2.0
An individual carrying duplications of functional alleles
*1/*1xN, *1/*2xN, *2/*2×N°
(~1-2% of patients)ª
Extensive metabolizer
2.0-1.0°
An individual carrying two normal function alleles or two
*1/*1, *1/*2, *1/*4, *1/*5,
*1/*9, *1/*41, *2/*2,*41/*41
(~77-92% of patients)
decreased function alleles or one normal function and
one no function allele or one normal function and one
decreased function allele
Intermediate metabolizer
0.5
An individual carrying one decreased function and one
no function allele
*4/*10, *4/*41, *5/*9
(~2-11% of patients)
Poor metabolizers
(~5-10% of patients)
An individual carrying only no functional alleles
*3/*4, *4/*4, *5/*5, *5/*6
Transcribed Image Text:Table 1 Assignment of likely phenotypes based on diplotypes Table 1a Assignment of CYP2D6 predicted phenotypes Likely phenotype Activity score Genotypes Examples of CYP2D6 diplotypes Ultrarapid metabolizer > 2.0 An individual carrying duplications of functional alleles *1/*1xN, *1/*2xN, *2/*2×N° (~1-2% of patients)ª Extensive metabolizer 2.0-1.0° An individual carrying two normal function alleles or two *1/*1, *1/*2, *1/*4, *1/*5, *1/*9, *1/*41, *2/*2,*41/*41 (~77-92% of patients) decreased function alleles or one normal function and one no function allele or one normal function and one decreased function allele Intermediate metabolizer 0.5 An individual carrying one decreased function and one no function allele *4/*10, *4/*41, *5/*9 (~2-11% of patients) Poor metabolizers (~5-10% of patients) An individual carrying only no functional alleles *3/*4, *4/*4, *5/*5, *5/*6
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Phlebotomy Essentials
Phlebotomy Essentials
Nursing
ISBN:
9781451194524
Author:
Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:
JONES+BARTLETT PUBLISHERS, INC.
Gould's Pathophysiology for the Health Profession…
Gould's Pathophysiology for the Health Profession…
Nursing
ISBN:
9780323414425
Author:
Robert J Hubert BS
Publisher:
Saunders
Fundamentals Of Nursing
Fundamentals Of Nursing
Nursing
ISBN:
9781496362179
Author:
Taylor, Carol (carol R.), LYNN, Pamela (pamela Barbara), Bartlett, Jennifer L.
Publisher:
Wolters Kluwer,
Fundamentals of Nursing, 9e
Fundamentals of Nursing, 9e
Nursing
ISBN:
9780323327404
Author:
Patricia A. Potter RN MSN PhD FAAN, Anne Griffin Perry RN EdD FAAN, Patricia Stockert RN BSN MS PhD, Amy Hall RN BSN MS PhD CNE
Publisher:
Elsevier Science
Study Guide for Gould's Pathophysiology for the H…
Study Guide for Gould's Pathophysiology for the H…
Nursing
ISBN:
9780323414142
Author:
Hubert BS, Robert J; VanMeter PhD, Karin C.
Publisher:
Saunders
Issues and Ethics in the Helping Professions (Min…
Issues and Ethics in the Helping Professions (Min…
Nursing
ISBN:
9781337406291
Author:
Gerald Corey, Marianne Schneider Corey, Cindy Corey
Publisher:
Cengage Learning